Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

Documenti analoghi

• Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine
  di: Huang, Claire Y.-H., et al.
  Pubblicazione: (2000)
• Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5′ Noncoding Region and Nonstructural Proteins 1 and 3
  di: Butrapet, Siritorn, et al.
  Pubblicazione: (2000)
• Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
  di: Osorio, Jorge E., et al.
  Pubblicazione: (2011)
• Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus
  di: Huang, Claire Y.-H., et al.
  Pubblicazione: (2005)
• Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
  di: Guirakhoo, F., et al.
  Pubblicazione: (2004)